Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? - Wikidata - wikimedia - TriplyDB

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

http://www.wikidata.org/entity/Q47734769

about

Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma Transcatheter arterial embolisation and chemoembolisation for hepatocellular carcinoma Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions Thymostimulin in advanced hepatocellular carcinoma: a phase II trial A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma Systemic treatment of hepatocellular carcinoma: Past, present and future Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition Primary liver tumors.Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells.Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma Hepatocellular carcinoma--cause, treatment and metastasis.Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial.Imaging Intratumoral Nanoparticle Uptake After Combining Nanoembolization with Various Ablative Therapies in Hepatic VX2 Rabbit Tumors.Future perspectives for hepatocellular carcinoma.Hepatocellular carcinoma: therapy and prevention.Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study.Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinoma.Asia-Pacific consensus guidelines on gastric cancer prevention.Is human hepatocellular carcinoma a hormone-responsive tumor?Thalidomide for treating metastatic hepatocellular carcinoma: a pilot study.Systemic therapy for advanced hepatocellular carcinoma: past, present, and future.Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines.Advances in Local and Systemic Therapies for Hepatocellular Cancer.OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer.Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma.Hepatocellular carcinoma: the place of new medical therapies.Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trial Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients.Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients.Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.

P2860

Q21092852-4F471907-29F1-40CD-806C-6B33D13CB06F Q24247259-7C43014C-991E-4B0E-AD5E-0360312BF35C Q24309608-76E0E2DC-8D31-46E3-8329-37D7D3493C1E Q24628144-D805B666-B786-42D3-854D-20A2F0D0EE48 Q25257445-6E434E63-385C-4313-A690-EEEB219E8040 Q27007847-FA1E80BF-2D79-48F3-960C-8B504A2FA517 Q33325625-C0AC8EE7-4A4C-45B6-9271-C56EB174804A Q33343204-73C85EE3-6E96-44CE-A706-4A5CDA2E2A1E Q33358104-C952D133-4886-4463-A51E-0BE5A9A493A2 Q33742856-9FFAA644-4E69-4E54-8231-9CD0B0C32029 Q33854034-3A6DD5B7-097E-4F15-997F-B05B96DF4021 Q33886179-C75E8322-4830-4759-861F-0C90E6132B55 Q34110964-2AF57B5C-705C-423B-A4D0-F64DBA459B80 Q34233172-00E36FA5-2117-4818-BA88-6538FD2BE5B4 Q34364217-9E59895A-7588-4C29-A4C0-3099B611829C Q34512068-1683369C-DB2A-4CCB-8CA8-A115B95D0955 Q35078518-A24E884F-CDD5-448E-80FC-9E748B67E183 Q36053235-0D96D887-BB6C-49C4-8032-E311E7BBEB25 Q36063224-AD759C7D-219E-422B-97B9-E0B8DED3B0E8 Q36377949-E0DA46F1-1120-4CE6-9B2F-E4C90EA8AC26 Q36497118-503783C5-7679-4866-A796-B8C273726A77 Q36611050-C3BAF982-1EC1-4CC9-A66D-5FFDBEB9B509 Q36945072-4DCD0B0C-E48B-4D63-BC92-9E4525B6B38F Q37101686-B61036A2-838E-47C3-BBA8-F90F713181B2 Q37113547-7DC2331E-BE2F-4B33-941B-154B7BAD1BA8 Q37475722-35C2FE4B-A4EE-430C-B631-7117123E3D4A Q37734197-247F43A6-0538-4B8F-8C41-3F0D567183C0 Q37988322-7C55BFFD-B35F-478B-BD47-14DDEE22FDAE Q38697243-3B371052-D818-4204-816F-C4FB591F2A99 Q38911638-70EA5F6B-BBF8-4B03-8D59-20F9D808DF8D Q39478032-E1710AD7-2B99-4BC6-9F32-CFA8D89E7070 Q39895781-9020AD29-9530-43E0-8D4B-C3525CB0D863 Q40173544-219C427E-6F9E-4061-9D82-D41C3F5A8CC1 Q41174836-0C9B6455-1417-4321-874F-2269FC4EAA82 Q42362049-8E8CAD46-F26B-42D9-B924-69246819387D Q43924482-C908B767-E7CC-4219-A15F-FE34411B450E Q44172632-BF562D12-5B06-41AC-B8AE-B459101F41B6 Q44256489-89C19EF8-FE58-4421-99CE-7161ED94E55D Q44902518-BB82CBE4-3B72-4D09-B873-0CC6D023E9A5 Q46905311-436ECF4B-F5AF-4AA3-BA76-EFE5D35651EA

P2860

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

http://www.wikidata.org/entity/Q47734769

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Review article: Overview of me ...... --an impossible meta-analysis?

@en

Review article: Overview of me ...... --an impossible meta-analysis?

@nl

type

label

Review article: Overview of me ...... --an impossible meta-analysis?

@en

Review article: Overview of me ...... --an impossible meta-analysis?

@nl

prefLabel

Review article: Overview of me ...... --an impossible meta-analysis?

@en

Review article: Overview of me ...... --an impossible meta-analysis?

@nl

P1433

Q47734769-FF2E8DB2-FBA6-421C-8B2C-8DEEA25B0351

P1476

Q47734769-4E972E59-12A9-4993-9AB7-0E8AD5C8B908

P2093

Q47734769-22808B31-C694-4003-894D-6AB8F77C6B9C

Q47734769-3BFC33BF-8BFB-437D-8A65-A63F2DA8AC79

Q47734769-840FCCD4-7CC7-4F61-9AF2-EF4476555B37

Q47734769-95189A57-F6D8-4A55-BDD6-4849DAF6B270

Q47734769-9E620B9E-DEA0-4B4C-B630-419451FEDA02

Q47734769-A748122C-BC08-42DD-A023-918528D89E8A

Q47734769-B9157A5A-A848-45FE-9A88-F8CA955DC6DB

Q47734769-CF17F96F-B925-41FE-A22A-08D2A40F34CA

P2860

Q47734769-0FD4B57D-0000-45E4-BF70-23CF1DB0D11E

Q47734769-22D65244-2D69-4217-92ED-975516168A2A

Q47734769-3009F7BF-8D37-403C-B22C-FFA987E62739

Q47734769-4814469D-2C5C-4A96-8113-5E451B7D72CA

Q47734769-496536CA-7F41-4A9C-8BD3-89E04DD09976

Q47734769-4EE13C9E-340F-452C-9D76-8090AB94BF21

Q47734769-54E3B090-F578-4A36-B95B-7667F3943485

Q47734769-5A77A496-3B3D-4A68-BE40-772E71E599A9

Q47734769-5A8F14E3-A347-441E-B037-55929BFB6402

Q47734769-629F46FE-8C30-46DA-B808-AC35E23DCA21

P304

Q47734769-D2B655D2-EC1E-4C06-BFC0-D56981BE7F49

P31

Q47734769-5b4b8e41-a44f-45a3-ade5-44b72861be85

Q47734769-81045886-C310-45E8-B055-205FCEF21167

P356

Q47734769-1E72499B-4E9A-4C3D-BBDF-74291B103F65

P407

Q47734769-A2B2F9CC-2FCB-4522-96DF-51EDAB470F7B

P433

Q47734769-8A539F15-8D3E-46E1-B0D8-3CF57FE5748B

P478

Q47734769-4E12022A-BB56-4ECA-B44D-FF63205E6748

P50

Q47734769-F345186F-71B8-4C81-B69A-7041D41B28FC

P577

Q47734769-932B782E-6161-437B-85D3-AAEEBA69518A

P5875

Q47734769-5A63C87F-1890-4C89-A099-FF001CE4F5B8

P698

Q47734769-475DCCC5-3F26-488D-B60A-9806C277ED71

P921

Q47734769-0C368D91-7AF9-43ED-8BA5-48405162B3A7

P356

J.1365-2036.1998.00286.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Review article: Overview of me ...... --an impossible meta-analysis?

@en

P2093

Bellin MF

http://www.w3.org/2001/XMLSchema#string

Bernard B

http://www.w3.org/2001/XMLSchema#string

Carbonell N

http://www.w3.org/2001/XMLSchema#string

Cluzel P

http://www.w3.org/2001/XMLSchema#string

Khayat D

http://www.w3.org/2001/XMLSchema#string

Mathurin P

http://www.w3.org/2001/XMLSchema#string

Opolon P

http://www.w3.org/2001/XMLSchema#string

Rixe O

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis in clinical trials

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.

Neocarzinostatin versus m-AMSA or doxorubicin in hepatocellular carcinoma.

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma.

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study.

5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases.

Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma.

P304

111-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2036.1998.00286.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Thierry Poynard

P577

1998-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13591943

http://www.w3.org/2001/XMLSchema#string

P698

9692685

http://www.w3.org/2001/XMLSchema#string

P921